Overview
DNA market data
Price History
DNA price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$5.64 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.88 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -215.4% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $5.37 – $17.58 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $487.5M · P/B 0.99 · P/S 3.45.
Company News
TD Cowen Downgrades Ginkgo Bioworks Holdings to Hold, Lowers Price Target to $9Benzinga · Aug 7, 2026, 8:30 PM
U.S. CDC Says Will Enhance Screening And Monitoring Of Travelers Arriving From Areas Affected By Ebola Outbreaks; Will Coordinate With Airlines, Others To Manage Travelers Who May Have Already Been Exposed To Ebola; Will Enhance Contract Tracing, Hospital Readiness NationwideBenzinga · May 18, 2026, 3:30 PM